GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (OTCPK:ERFSF) » Definitions » Beneish M-Score

Eurofins Scientific SE (Eurofins Scientific SE) Beneish M-Score : -2.81 (As of Apr. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Eurofins Scientific SE Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.81 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Eurofins Scientific SE's Beneish M-Score or its related term are showing as below:

ERFSF' s Beneish M-Score Range Over the Past 10 Years
Min: -2.81   Med: -2.58   Max: -2.29
Current: -2.81

During the past 13 years, the highest Beneish M-Score of Eurofins Scientific SE was -2.29. The lowest was -2.81. And the median was -2.58.


Eurofins Scientific SE Beneish M-Score Historical Data

The historical data trend for Eurofins Scientific SE's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Beneish M-Score Chart

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.69 -2.71 -2.63 -2.75 -2.81

Eurofins Scientific SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.63 - -2.75 - -2.81

Competitive Comparison of Eurofins Scientific SE's Beneish M-Score

For the Diagnostics & Research subindustry, Eurofins Scientific SE's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's Beneish M-Score falls into.



Eurofins Scientific SE Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Eurofins Scientific SE for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0564+0.528 * 0.9976+0.404 * 0.9132+0.892 * 0.9992+0.115 * 0.9563
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.064995-0.327 * 1.0328
=-2.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $1,634 Mil.
Revenue was $7,104 Mil.
Gross Profit was $4,758 Mil.
Total Current Assets was $3,344 Mil.
Total Assets was $11,874 Mil.
Property, Plant and Equipment(Net PPE) was $2,505 Mil.
Depreciation, Depletion and Amortization(DDA) was $616 Mil.
Selling, General, & Admin. Expense(SGA) was $0 Mil.
Total Current Liabilities was $2,314 Mil.
Long-Term Debt & Capital Lease Obligation was $3,626 Mil.
Net Income was $338 Mil.
Gross Profit was $0 Mil.
Cash Flow from Operations was $1,110 Mil.
Total Receivables was $1,548 Mil.
Revenue was $7,110 Mil.
Gross Profit was $4,751 Mil.
Total Current Assets was $2,451 Mil.
Total Assets was $10,682 Mil.
Property, Plant and Equipment(Net PPE) was $2,296 Mil.
Depreciation, Depletion and Amortization(DDA) was $534 Mil.
Selling, General, & Admin. Expense(SGA) was $0 Mil.
Total Current Liabilities was $1,877 Mil.
Long-Term Debt & Capital Lease Obligation was $3,296 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1634.351 / 7104.253) / (1548.411 / 7110.275)
=0.230052 / 0.217771
=1.0564

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4751.165 / 7110.275) / (4758.451 / 7104.253)
=0.668211 / 0.669803
=0.9976

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3343.948 + 2505.344) / 11874.155) / (1 - (2450.53 + 2296.292) / 10681.674)
=0.507393 / 0.555611
=0.9132

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=7104.253 / 7110.275
=0.9992

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(534.322 / (534.322 + 2296.292)) / (616.14 / (616.14 + 2505.344))
=0.188765 / 0.197387
=0.9563

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 7104.253) / (0 / 7110.275)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3626.499 + 2313.74) / 11874.155) / ((3296.398 + 1877.331) / 10681.674)
=0.500266 / 0.484356
=1.0328

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(338.277 - 0 - 1110.033) / 11874.155
=-0.064995

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Eurofins Scientific SE has a M-score of -2.79 suggests that the company is unlikely to be a manipulator.


Eurofins Scientific SE Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE (Eurofins Scientific SE) Business Description

Traded in Other Exchanges
Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.

Eurofins Scientific SE (Eurofins Scientific SE) Headlines

From GuruFocus

Eurofins DiscoverX Celebrates Shanghai Office Opening

By PRNewswire PRNewswire 07-09-2022

Viracor Eurofins Announces Medical Advisory Board

By PRNewswire PRNewswire 08-22-2018